Washington, D.C. 20549
Form 8-K
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 8, 2021
AquaBounty Technologies, Inc.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
of incorporation)
File Number)
(IRS Employer
Identification No.)

2 Mill & Main Place, Suite 395, Maynard, Massachusetts
(Address of principal executive offices)
(Zip Code)

(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)

Title of each class Trading Symbol(s) Name of exchange on which registered
Common Stock, par value $0.001 per share
AQB The NASDAQ Stock Market LLC
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company     ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

Item 8.01. Other Events.
As previously reported, on February 3, 2021, AquaBounty Technologies, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Oppenheimer & Co. Inc. and Lake Street Capital Markets, LLC, as the representatives of the underwriters named therein (the “Underwriters”), relating to the underwritten public offering (the “Offering”) at a public offering price of $8.50 per share of up to an aggregate of 14,950,000 shares of the Company’s common stock (the “Shares”), which includes an over-allotment option granted to the Underwriters, exercisable for 30 days, to purchase up to 1,950,000 shares.
On February 8, 2021, the Company consummated the sale of the Shares at a public offering price of $8.50 per share, including the full exercise of the underwriters’ over-allotment option, generating gross proceeds of approximately $127.1 million. After deducting underwriting discounts and commissions, the Company estimates the net proceeds will be approximately $119.2 million.
The Offering and sale of the Shares was made pursuant to a prospectus supplement dated February 5, 2021, which is part of the Company’s Registration Statement on Form S-3 (File No. 333-252264), which was filed on January 20, 2021 and declared effective by the Securities and Exchange Commission on January 25, 2021.
On February 8, 2021, the Company issued a press release regarding the closing of the Offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01  Financial Statements and Exhibits.
(d) Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AquaBounty Technologies, Inc.
February 8, 2021 /s/ David A. Frank
David A. Frank
Chief Financial Officer